Health Canada’s website today reflects the granting of two new licenses to cultivate medical cannabis. Green Relief, based in Ontario, and THC Biomed (CSE:THC) (OTC:THCBF), based in British Columbia, received the 28th and 29th licenses.
The companies will now be permitted to cultivate but must go through product testing and final approval by Health Canada before they can sell to registered patients. The agency approved an additional facility for Mettrum (TSXV:MT) in December, but these are the first new approvals since the KindCann license grant in August and the first since the Liberals took control of Parliament.
Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email